Literature DB >> 12367789

Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung.

Masao Chujo1, Tsuyoshi Noguchi, Takashi Miura, Mitsuyuki Arinaga, Yuzo Uchida, Yutaka Tagawa.   

Abstract

The aim of this study was to provide cytogenetic data about squamous cell carcinomas of the lung and to evaluate their characteristic alterations and histogenetic relations. We analyzed 41 squamous cell lung carcinomas by comparative genomic hybridization (CGH) technique. CGH was performed using directly fluorochrome-conjugated DNA. Chromosomal regions where the mean ratio fell below 0.75 were therefore considered to reflect DNA copy number loss (underrepresentation), whereas regions where the mean ratio exceeded 1.25 were considered gains (overrepresentations) in the tumor genome. Overrepresentations were considered to be high-level amplification when the fluorescence ratio exceeded 1.5. Chromosomal imbalances were observed in every case. Copy number gains frequently were detected at 3q, 5p, 8q, 12p, and Xq. Losses were found at 16p, 4q, 5q, 3p, 17p, and 16q. DNA amplifications were observed at 12 regions: 3q26.1-27, 8q13-23.1, 12p12.3-pter, 12q15, 2p14-16, 4q28-31.2, 5p13.1-pter, 6q21-22.3, 7p11.2-13, 13q21.2-32, 18p11.2-pter, and 20p11.2-pter. Gains on 3q were frequently detected not only in the more than 3 cm group (79%) but also in the 3 cm or less group (77%). The mean frequency of gained or lost chromosomal regions was 7.2+/-4.7 in the 3 cm or less group (n=13) and 10.2+/-6.3 in the more than 3 cm group (n=28) (P=0.4503). The mean frequency of gained or lost chromosomal regions was significantly higher in the carcinoma with lymph node metastasis group (12.5+/-7.6 regions) (n=12) than in the carcinoma without lymph node metastasis group (7.9+/-4.6) (n=29) (P=0.0251). In conclusion, an increased copy number at 3q may contribute to the development of squamous cell carcinoma of the lung.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12367789     DOI: 10.1016/s0169-5002(02)00151-4

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  18 in total

1.  DeltaN TP63 reactivation, epithelial phenotype maintenance, and survival in lung squamous cell carcinoma.

Authors:  Karine Pallier; Aurélie Cazes; Laila El Khattabi; Cristina Lecchi; Marine Desroches; Claire Danel; Marc Riquet; Elizabeth Fabre-Guillevin; Pierre Laurent-Puig; Hélène Blons
Journal:  Tumour Biol       Date:  2011-10-11

2.  The chromosome 3q26 OncCassette: A multigenic driver of human cancer.

Authors:  Alan P Fields; Verline Justilien; Nicole R Murray
Journal:  Adv Biol Regul       Date:  2015-12-23

3.  RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.

Authors:  Ya-Nan Liang; Yu Liu; Qingwei Meng; Xiaobo Li; Fan Wang; Guodong Yao; Letian Wang; Songbin Fu; Dandan Tong
Journal:  Med Oncol       Date:  2015-01-15       Impact factor: 3.064

4.  Combinational chromosomal aneuploidies and HPV status for prediction of head and neck squamous cell carcinoma prognosis in biopsies and cytological preparations.

Authors:  Silke Wemmert; Maximilian Linxweiler; Cornelia Lerner; Florian Bochen; Philipp Kulas; Johannes Linxweiler; Sigrun Smola; Steffi Urbschat; Stefan Wagenpfeil; Bernhard Schick
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-20       Impact factor: 4.553

5.  Comparative genomic hybridization array analysis and real-time PCR reveals genomic copy number alteration for lung adenocarcinomas.

Authors:  Jin Soo Choi; Long Tai Zheng; Eunyoung Ha; Yun Jeong Lim; Yeul Hong Kim; Young-Pil Wang; Young Lim
Journal:  Lung       Date:  2006-11-03       Impact factor: 2.584

6.  gammaH2AX: A potential DNA damage response biomarker for assessing toxicological risk of tobacco products.

Authors:  Anthony P Albino; Ellen D Jorgensen; Patrick Rainey; Gene Gillman; T Jeffrey Clark; Diana Gietl; Hong Zhao; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Mutat Res       Date:  2009-07-08       Impact factor: 2.433

7.  Array CGH reveals genomic aberrations in human emphysema.

Authors:  Jin Soo Choi; Woon Jeong Lee; Seung Ho Baik; Hyoung Kyu Yoon; Kweon-Haeng Lee; Yeul Hong Kim; Young Lim; Young-Pil Wang
Journal:  Lung       Date:  2009-04-08       Impact factor: 2.584

Review 8.  Advanced molecular cytogenetics in human and mouse.

Authors:  Kathleen Dorritie; Cristina Montagna; Michael J Difilippantonio; Thomas Ried
Journal:  Expert Rev Mol Diagn       Date:  2004-09       Impact factor: 5.225

9.  DNA profiling by array comparative genomic hybridization (CGH) of peripheral blood mononuclear cells (PBMC) and tumor tissue cell in non-small cell lung cancer (NSCLC).

Authors:  Seung-Ho Baik; Bo-Keun Jee; Jin-Soo Choi; Hyoung-Kyu Yoon; Kweon-Haeng Lee; Yeul-Hong Kim; Young Lim
Journal:  Mol Biol Rep       Date:  2008-11-01       Impact factor: 2.316

10.  Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.

Authors:  Ji Un Kang; Sun Hoe Koo; Kye Chul Kwon; Jong Woo Park; Jin Man Kim
Journal:  BMC Cancer       Date:  2009-07-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.